SYNB1891, A BACTERIUM ENGINEERED TO PRODUCE A STING AGONIST, DEMONSTRATES TARGET ENGAGEMENT IN HUMANS FOLLOWING INTRATUMORAL INJECTION

被引：3

作者：

Riese, Richard ^{[1
]}

Luke, Jason ^{[2
]}

Lewis, Karl ^{[3
]}

Janku, Filip ^{[4
]}

Piha-Paul, Sarina ^{[4
]}

Verschraegen, Claire ^{[5
]}

Brennan, Aoife ^{[1
]}

Armstrong, Michael ^{[6
]}

Varterasian, Mary ^{[7
]}

Sokolovska, Anna ^{[1
]}

Strauss, James ^{[8
]}

机构：

[1] Synlogic Inc, Cambridge, MA USA

[2] UPMC, Hillman Canc Ctr, Pittsburgh, PA USA

[3] Univ Colorado, Aurora, CO USA

[4] Univ Texas Houston, Houston, TX USA

[5] Ohio State Univ, Columbus, OH USA

[6] IQVIA Biotech, Durham, NC USA

[7] Ann Arbor Drug Safety, LLC, Ann Arbor, MI USA

[8] Mary Crowley Canc Res, Dallas, TX USA

来源：

关键词：

D O I：

10.1136/jitc-2021-SITC2021.500

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

500

引用

页码：A532 / A532

页数：1

共 2 条